Dr. Ono is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 W 38th St Ste 307
Austin, TX 78705Phone+1 512-324-3028
Summary
- Dr. Masahiro Ono is a thoracic surgeon in Austin, TX and is affiliated with multiple hospitals in the area, including Ascension Seton Medical Center Austin. He also speaks multiple languages, including Japanese. He specializes in adult cardiac surgery and cardiopulmonary transplantation and is experienced in cardiogenic shock, ventricular assist device implantation, extracorporeal membrane oxygenation, adult cardiac surgery, and lung transplant surgery.
Education & Training
- Texas Heart InstituteFellowship, Thoracic Surgery, 2013 - 2016
- Johns Hopkins UniversityPost-Doctoral Fellowship, Thoracic Surgery, 2010 - 2013
- Showa University School of MedicinePh.D., 2009
Certifications & Licensure
- NM State Medical License 2020 - 2026
- TX State Medical License 2019 - 2025
Awards, Honors, & Recognition
- Branislav Radovancevic Memorial Fellowship Grant Award International Society for Heart & Lung Transplantation, 2013
- 14th Annual ACCM Research Day Academic Award Johns Hopkins Hospital, 2012
- 17th Annual Anselm Talalay Vincent Gott Cardiac Research Prize Winner Johns Hopkins Hospital, 2011
- Join now to see all
Clinical Trials
- Individual Blood Pressure Optimization Based on Cerebral Autoregulation After Implantation of Continuous-flow LVAD Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- Novel portable hypothermic machine perfusion preservation device enhances cardiac viability of donated human hearts.Kristina Andrijauskaite, Rafael J Veraza, Riley P Lopez, Zach Maxwell, Isabella Cano
Frontiers in Cardiovascular Medicine. 2024-01-01 - 10 citationsSingle center experience and early outcomes of Impella 5.5.Masaki Funamoto, Chandra Kunavarapu, Michael D Kwan, Yuichi Matsuzaki, Mahek Shah
Frontiers in Cardiovascular Medicine. 2023-01-01 - 10 citationsCOMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device.Steven R Allen, Mark S Slaughter, Mustafa M Ahmed, Carlo R Bartoli, Ravi Dhingra
The Journal of Heart and Lung Transplantation. 2023-01-01
Journal Articles
- Regional Heterogenelty of Cerebral Cortical Hemoglobin Concentrations Measured with Cerebral Optical Topography During Cardiac Surgery in AdultsGottschalk A, Ono M, Hogue CW, Anesthesia and Analgesia, 1/1/2015
- Rewarming Rate During Cardiopulmonary Bypass Is Associated with Release of Glial Fibrillary Acidicic ProteinHori D, Everett AD, Lee JK, Ono M, Brown CH, Shah AS, Mandal K, Price JE, Lester LC, Hogue CW, Annals of Thoracic Surgery, 1/1/2015
- Hypotension After Cardiac Operations Based on Autoregulation Monitoring Leads to Brain Cellular InjuryHori D, Ono M, Rappold TE, Conte JV, Shah AS, Cameron DE, Adachi H, Everett AD, Hogue CW, Annals of Thoracic Surgery, 1/1/2015
- Join now to see all
Abstracts/Posters
- Individual Optimal Blood Pressure Determined by Cerebral Autoregulation Monitoring During and After Continuous-Flow Left Ventricular Assist Device ImplantationOno M, Singh SK, Kibler KK, Easley RB, Brady KM, 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Washington, DC, 1/27/2016
- Preoperative Risk Factors for Stroke After HeartWare Left Ventricular Assist Device Implantation: Texas Heart Institute ExperienceOno M, Singh SK, Cohn WE, Civitello AB, Frazier OH, 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Washington, DC, 1/27/2016
- Optimal Blood Pressure during Cardiopulmonary Bypass defined by Cerebral Autoregulation Monitoring and its association with Severe Coronary Artery DiseaseHori D, Nomura Y, Ono M, Joshi B, Mandal K, Cameron ED, Hogue CW, 96th Annual Meeting of the American Association for Thoracic Surgery, Baltimore, MD, 1/14/2016
- Join now to see all
Press Mentions
- Multi-Center, Multi-Society Study of Impella-Supported Patients with Cardiogenic Shock Due to Myocarditis in Japan Achieves 30-Day Survival of 77%September 20th, 2022
- Triple Therapy Demonstrates 100% Cure Rate in Mouse Model of MelanomaMay 26th, 2022
- Auf Der STS-Jahrestagung Vorgestellte Umfangreiche Klinische Studie Zeigt Überlebensrate Von 79 % Bei Behandlung Mit Impella 5.5 Mit SmartAssist HerzpumpeFebruary 1st, 2021
- Join now to see all
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: